Clearstead Advisors’s Chemed CHE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$51.2K Buy
110
+98
+817% +$41.2K ﹤0.01% 1487
2026
Q1
$4.53K Sell
12
-75
-86% -$32.1K ﹤0.01% 1755
2025
Q4
$37.2K Sell
87
-44
-34% -$19.2K ﹤0.01% 1512
2025
Q3
$58.7K Sell
131
-97
-43% -$43.9K ﹤0.01% 1232
2025
Q2
$111K Buy
228
+37
+19% +$21.1K ﹤0.01% 1038
2025
Q1
$118K Sell
191
-311
-62% -$177K ﹤0.01% 948
2024
Q4
$266K Sell
502
-115
-19% -$64.8K ﹤0.01% 767
2024
Q3
$371K Sell
617
-46
-7% -$26.1K 0.01% 649
2024
Q2
$360K Buy
+663
New +$380K 0.01% 621
2024
Q1
Sell
-3
Closed -$1.75K 1556
2023
Q4
$1.75K Sell
3
-8
-73% -$4.48K ﹤0.01% 1304
2023
Q3
$5.72K Buy
11
+8
+267% +$4.16K ﹤0.01% 1068
2023
Q2
$1.63K Sell
3
-3
-50% -$1.64K ﹤0.01% 1190
2023
Q1
$3.23K Buy
+6
New +$3.06K ﹤0.01% 1072
2022
Q3
Sell
-198
Closed -$93K 1264
2022
Q2
$93K Hold
198
0.01% 511
2022
Q1
$100K Hold
198
0.01% 552
2021
Q4
$105K Buy
+198
New +$95.1K 0.01% 515

Other funds holding CHE

Clearstead Advisors's CHE Position: Q2 2026 in Review

Clearstead Advisors increased its Chemed (CHE) stake by 817% in Q2 2026, buying an estimated $41.2K and bringing the position to 110 shares worth $51.2K. The position accounts for ﹤0.01% of the portfolio, ranked #1487.

Clearstead Advisors first reported a position in CHE in Q4 2021 and has held it in 16 quarters since. The position peaked at $371K in Q3 2024. 532 funds tracked by Wall St. Rank hold CHE as of Q2 2026.

  • Clearstead Advisors held 110 shares of Chemed worth $51.2K as of Q2 2026.
  • Clearstead Advisors bought 98 Chemed shares in Q2 2026, an estimated $41.2K.
  • Chemed made up ﹤0.01% of Clearstead Advisors's portfolio in Q2 2026, its #1487 holding.
  • Clearstead Advisors first reported a position in Chemed in Q4 2021 and has held it in 16 quarters since.
  • Clearstead Advisors's Chemed position peaked at $371K in Q3 2024.
  • 532 funds tracked by Wall St. Rank held Chemed as of Q2 2026.

Based on Clearstead Advisors's 13F filing for Q2 2026, filed 6 Aug 2026.